Hamre, Schumann, Mueller & Larson, P.C.
Use of NADH or salt thereof in preparation of drugs or health-care products for treating phenylketonuria
Disclosed is use of nicotinamide adenine dinucleotide (NADH) or a salt thereof in the preparation of drugs or health-care products for treating phenylketonuria (PKU), wherein a single dose of the NADH or a salt thereof is 1-100 mg.
HOBOOMLIFE BIO-TECHNOLOGY CO., LTD.
A A A A
A61K A61K A61P A61K
inventional inventional inventional inventional
Rongzhao Qi Yuemei
Fu Zhang Liu